Polycystic Ovary Syndrome: Current Evidence and Practical Recommendations

    February 2020 in “ Diabetologie Und Stoffwechsel ”
    Susanne Tan, Christian Böing, Dagmar Führer-Sakel
    Image of study
    TLDR The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).
    The document from February 1, 2020, summarizes the management of Polycystic Ovary Syndrome (PCOS), including diagnostic criteria based on the Rotterdam criteria and the importance of insulin resistance (IR) in the condition. It notes that 95% of overweight and 75% of normal-weight women with PCOS show IR, but IR measurement is not recommended for diagnosis or treatment decisions. The document emphasizes lifestyle changes as the foundation of PCOS treatment and discusses pharmacological treatments like Metformin, particularly for women with a BMI >25 kg/m². It also covers the use of oral contraceptive pills, Letrozole as the first-line therapy for fertility, and Metformin as an alternative, with IVF as a third-line therapy. For symptoms like hirsutism, alopecia, and acne, local treatments and systemic OCPs are recommended, with antiandrogens as a potential first-line therapy in some cases. The document mentions experimental treatments like Inositol and antidiabetic medications and concludes with a call for more research to include new treatments in PCOS guidelines.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 25 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 1 month ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.

    Similar Research

    6 / 1000+ results